MY144022A - Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation - Google Patents

Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation

Info

Publication number
MY144022A
MY144022A MYPI20080125A MY144022A MY 144022 A MY144022 A MY 144022A MY PI20080125 A MYPI20080125 A MY PI20080125A MY 144022 A MY144022 A MY 144022A
Authority
MY
Malaysia
Prior art keywords
vial
syringe
chondrocyte
injecting
transplanting
Prior art date
Application number
Inventor
Chang-Kwon Ko
Eun-Young Lee
Jeong-Yong Choi
Jae-Deog Jang
Cheong-Ho Chang
Pyoung-Min Kim
Original Assignee
Sewon Cellontech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sewon Cellontech Co Ltd filed Critical Sewon Cellontech Co Ltd
Priority to MYPI20080125 priority Critical patent/MY144022A/en
Publication of MY144022A publication Critical patent/MY144022A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

THE PRESENT INVENTION RELATES TO A METHOD OF TRANSPLANTING AN INJECTABLE CHONDROCYTE FOR AUTOLOGOUS CHONDROCYTE TRANSPLANTATION. FOR THIS PURPOSE, THE PRESENT INVENTION PROVIDES A METHOD OF TRANSPLANTING AN INJECTABLE CHONDROCYTE FOR AUTOLOGOUS CHONDROCYTE TRANSPLANTATION, COMPRISING MIXING MATRICES INCLUDING FIBRIN, HYALURONIC ACID AND COLLAGEN, CONSTITUTING MAIN INGREDIENTS OF ANIMAL CARTILAGE, VIA USE OF A FRONT END MIXING TIP OF A SYRINGE, WHILE INJECTING THE RESULTING MIXTURE INTO A DAMAGED CARTILAGE REGION. FURTHER, THE PRESENT INVENTION PROVIDES A METHOD OF TRANSPLANTING AN INJECTABLE CHONDROCYTE FOR AUTOLOGOUS CHONDROCYTE TRANSPLANTATION, COMPRISING PLACING 1 ML OF A CHONDROCYTE CULTURE CONTAINED IN VIAL NO. 1 (RED) INTO A 1 ML STERILE SYRINGE AND INJECTING THE CELL CULTURE INTO VIAL NO. 2 (BLUE) CONTAINING WHITE OR LIGHT-YELLOW LYOPHILIZED POWDER (FIBRINOGEN) BY INSERTING THE SYRINGE INTO VIAL NO. 2 IN THE VERTICAL DIRECTION, SUCH THAT THE CONCENTRATION OF FIBRINOGEN IS IN THE RANGE OF 10 MG/ML TO 200 MG/ML; INJECTING 1 ML OF CELL CULTURE CONTAINED IN VIAL NO. 1 (RED) INTO VIAL NO. 3 (RED, SMALL) CONTAINING WHITE LYOPHILIZED POWDER (THROMBIN) BY INSERTING THE SYRINGE INTO VIAL NO. 3 IN THE VERTICAL DIRECTION, THEREBY GRADUALLY INJECTING RED LIQUID; COLLECTING 0.1 CC OF 1 ML CONTENT OF VIAL NO. 3 (RED, SMALL) USING A 1 ML SYRINGE, FOLLOWED BY INJECTION INTO A BOTTOM OF VIAL NO.4 (YELLOW) SUCH THAT THE CONCENTRATION OF THROMBIN IS IN THE RANGE OF 1 IU/ML TO 200 IU/ML; ADDING THE ENTIRE CONTENTS OF TWO VIALS CONTAINING CHONDROCYTE SUSPENSION TO VIAL NO.4 (YELLOW) USING A 1ML STERILE SYRINGE, FOLLOWED BY MIXING THE CONTENTS TWO OR THREE TIMES USING THE SYRINGE; CONFIRMING COMPLETE DISSOLUTION OF THE CONTENTS OF VIAL NO.2 (BLUE) AND THEN INJECTING THE ENTIRETY OF THE DISSOLVED MATERIAL INTO A 1 ML SYRINGE; INJECTING THE WELL-MIXED CELL THERAPEUTIC AGENT OF VIAL 4 (YELLOW) INTO A 1 ML SYRINGE; AND MOUNTING TWO 1 ML SYRINGES FILLED WITH THE CONTENTS OF VIAL NO.2 (BLUE) AND VIAL NO.4 (YELLOW) ON A STANDING HOLDER FOLLOWED BY MOUNTING A SCREW TIP ON THE SYRINGES, AND MIXING THE CONTENTS OF THE SYRINGES USING FRONT END MIXING TIP THEREOF WHILE INJECTING THE RESULTING MIXTURE TO BE TRANSPLANTED INTO A DAMAGED CARTILAGE REGION OF AN ANIMAL. THE PRESENT INVENTION HAVING THE ABOVE-MENTIONED CONSTRUCTION PROVIDES ADVANTAGEOUS EFFECTS SUCH AS SOLUTION OF INCONVENIENCE EXHIBITED BY CONVENTIONAL OSTEOPERIOSTEAL GRAFTING, BY MIXING AND TRANSPLANTING MATRICES INCLUDING FIBRIN, HYALURONIC ACID AND COLLAGEN WHICH ARE MAIN INGREDIENTS OF CARTILAGE; TREATMENT OF A WIDE VARIETY OF CARTILAGE DEFECTS AND SEVERE OSTEOARTHRITIS; ALLEVIATION OF BURDEN OF PATIENTS TO BE TREATED VIA A SIMPLIFIED SURGICAL OPERATION METHOD; AND THEREBY PROMOTION OF RAPIDER AND MORE EFFECTIVE CARTILAGE GENERATION, RESULTING IN IMPROVED CUSTOMER SATISFACTION.
MYPI20080125 2008-01-22 2008-01-22 Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation MY144022A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20080125 MY144022A (en) 2008-01-22 2008-01-22 Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20080125 MY144022A (en) 2008-01-22 2008-01-22 Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation

Publications (1)

Publication Number Publication Date
MY144022A true MY144022A (en) 2011-07-29

Family

ID=45024100

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20080125 MY144022A (en) 2008-01-22 2008-01-22 Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation

Country Status (1)

Country Link
MY (1) MY144022A (en)

Similar Documents

Publication Publication Date Title
US10898497B2 (en) Compositions and methods for cartilage repair
Parisi-Amon et al. Protein-engineered injectable hydrogel to improve retention of transplanted adipose-derived stem cells
Colnot Cell sources for bone tissue engineering: insights from basic science
HRP20110321T1 (en) Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation
BR112013000515B1 (en) METHOD FOR PRODUCING A RECOMBINANT VON WILLEBRAND FACTOR COMPOSITION (RVWF)
CN102630157B (en) Injectable compositions for intra-articular use combining a viscosupplementation agent and a fibroblast growth medium
Miller et al. Growth factor delivery through self-assembling peptide scaffolds
Gugjoo et al. Animal mesenchymal stem cell research in cartilage regenerative medicine–a review
WO2009085969A2 (en) Compositions and methods to promote implantation and engrafment of stem cells
Barrachina et al. Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse
CA2551525C (en) Pharmaceutical composition for thrombin peptide derivatives
KR100803576B1 (en) A composition for transplant comprising adipose stem cells and adipocytes
CN104962517A (en) Preparation, induced differentiation and application of self-assembled mesenchymal stem cell aggregate
Bakshi et al. A chemotactic functional scaffold with VEGF-releasing peptide amphiphiles facilitates bone regeneration by BMP-2 in a large-scale rodent cranial defect model
Citterio et al. Stem cells and periodontal regeneration: present and future
Lyu et al. Parathyroid hormone 1 receptor signaling in dental mesenchymal stem cells: basic and clinical implications
HRP20110391T1 (en) Osteoblast composition of semi-solidified mixed fibrin for bone fracture agglutination and its manufacturing method
MY144022A (en) Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation
Vallim et al. Atrophic nonunion stromal cells form bone and recreate the bone marrow environment in vivo
KR100956267B1 (en) A semi-floating composition for transplant comprising elastin as a stabilizing agent
CN110755451A (en) Mesenchymal stem cell composition for treating osteoarthritis and application thereof
Yamazaki et al. Integrated Bone Formation Through In Vivo Endochondral Ossification Using Mesenchymal Stem Cells
Yamazaki et al. Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration
CN107320714A (en) Uncarboxylated BGP promotes the new opplication of insulin secretion
US20210137990A1 (en) Methods for exp anding adipose-derived stem cells